Evidence map›Paper›PMID 40691635›Full record

ArticleJournal of cheminformatics2025

Benchmarking ML in ADMET predictions: the practical impact of feature representations in ligand-based models.

Gintautas Kamuntavičius, Tanya Paquet, Orestis Bastas, Dainius Šalkauskas, Alvaro Prat, Hisham Abdel Aty, Aurimas Pabrinkis, Povilas Norvaišas, Roy Tal

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. The Tsetlin Machine: A "Third Way" in QSAR Modeling.Journal of chemical information and modeling · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Scaling Biomedical Text-Mining: Transformers, GenAI, and Drug Discovery.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gintautas Kamuntavičius *AI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA. gkamuntavicius@ro5.ai.
Tanya Paquet *AI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Orestis Bastas *AI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Dainius ŠalkauskasAI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Alvaro PratAI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Hisham Abdel AtyAI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Aurimas PabrinkisAI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Povilas NorvaišasAI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.
Roy TalAI Chemistry, Ro5, 2801 Gateway Drive, 75063, Irving, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study, focusing on predicting Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) properties, addresses the key challenges of ML models trained using ligand-based representations. We propose a structured approach to data feature selection, taking a step beyond the conventional practice of combining different representations without systematic reasoning. Additionally, we enhance model evaluation methods by integrating cross-validation with statistical hypothesis testing, adding a layer of reliability to the model assessments. Our final evaluations include a practical scenario, where models trained on one source of data are evaluated on a different one. This approach aims to bolster the reliability of ADMET predictions, providing more dependable and informative model evaluations.Scientific contributionThis study provided a structured approach to feature selection. We improve model evaluation by combining cross-validation with statistical hypothesis testing, making results more reliable. The methodology used in our study can be generalized beyond feature selection, boosting the confidence in selected models which is crucial in a noisy domain such as the ADMET prediction tasks. Additionally, we assess how well models trained on one dataset perform on another, offering practical insights for using external data in drug discovery.

Identifiers

PMID40691635
PMCPMC12281724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.